Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
about
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot studyDepurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer preventionThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityTetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.Contributions of human enzymes in carcinogen metabolismMethylation of dietary flavones increases their metabolic stability and chemopreventive effectsResveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.Cytochrome P450 family 1 inhibitors and structure-activity relationships.Nutrition and the prevention and treatment of cancer: association of cytochrome P450 CYP1B1 with the role of fruit and fruit extracts.Glaucoma in iran and contributions of studies in iran to the understanding of the etiology of glaucoma.Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cellsTransplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring.Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.The etiology and prevention of breast cancerTargeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolitesPharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.Improving metabolic stability of cancer chemoprotective polyphenols.cis-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells.A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallateExpression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell linesFetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene.Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells.Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes.Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.The citrus flavanone naringenin suppresses CYP1B1 transactivation through antagonising xenobiotic-responsive element binding.Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma.Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells.Inhibition of human cytochrome p450 1b1 further clarifies its role in the activation of dibenzo[a,l]pyrene in cells in culture.Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivativesInteraction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity.Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway.CYP1B1 detection.Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt.
P2860
Q24810286-FBFB7770-7891-4CE8-AA17-65A87D0D726CQ26765412-093FDC8A-52DF-4EF1-A029-A6846F09113EQ27021258-DA6454C5-7E86-4F92-9460-415101B7314FQ30393970-3A4A813C-4987-4A1A-B9AA-18E42AAD8D75Q30520640-98385FC6-0E6C-4668-B448-8F2AA32B0CC5Q33596822-730FB168-2325-4114-8C4E-19C47EC07A10Q34054119-8AD71441-B800-47F4-8D32-5D11F72D4878Q34436975-86E8C6AB-9C65-46D4-BBE3-73E5BF4FA486Q34912607-CB33CFF4-2F69-49C7-8272-968FD8240E17Q35584503-742B901F-752F-47BF-B078-CF622D2A08D2Q35585136-0BEDE314-5EFF-47CE-B79A-E62E0E9A4A13Q35718047-E39B0270-A563-4AE6-A713-A165F3CBB3E3Q35747349-DBF23512-FA0F-45F3-ABE7-25EDB324092FQ35855445-3425CF87-B7DC-420D-9602-33E080C923C3Q35910615-85C35C37-5D8D-45F1-AD53-653586F12827Q35962274-C540B39E-6A5E-4ADF-9AEF-2F72B2116203Q36571491-EA265D8E-D808-4EF2-93CF-0725C326E637Q36694528-B52DCCD2-CC9D-4584-B47F-E3CB091D9142Q36807739-11FFBF07-402C-4ABC-BE1E-36E339463FC9Q36835817-82C90D64-108E-4781-95F3-B11823936689Q36857890-EC6465FE-3AEC-4929-8765-8EF8357D509DQ36935966-7462C0FB-7546-4352-8881-6383819D29DCQ37210214-E67FC050-F2F8-4BBA-83C5-8C0B723371F1Q37216088-41ADCDCC-508F-40BA-9E9F-41E2D415A13EQ37246680-0262533B-7CC2-4CFE-B57C-E85647BB2429Q37404536-4092A733-6321-409C-8BFC-369D971CCB18Q38934642-480DE8AE-8DF8-439F-A0CA-8CE46E417BB6Q39227100-A9B458DC-574E-4F59-811A-23ADC1BCC84AQ39288160-E55C2EB2-EA4D-46F9-BC76-041F303D2FA0Q39582357-1DF67610-EE73-4BA3-BCA4-89E909678F17Q39639406-FB5559A8-C779-4CEC-B35D-829A343C1140Q39793072-4D321D38-237B-4DE7-B84F-2F983505751FQ40108777-B5B40ED1-AD52-45E0-900C-C06C86E5BECEQ41847479-3D61397A-7149-4506-AA7F-2FB1B4CC2D11Q42023392-DF781EBD-B3FF-4566-8A77-EE9E5DC9EA11Q42611138-972E6DE5-0D96-409D-B121-1B0E1D0E2D97Q42704155-9C5C7D4A-849E-49A1-9EC1-1F9F26979D56Q42718749-7AE3DB01-D10D-42FB-9BEF-9927266BACCBQ46245392-D18A8029-5CA2-4BB5-942B-BB308ED3D6F9Q46617198-B11FBBD0-EA43-4CD2-BDAC-2E05C2181D92
P2860
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@ast
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@en
type
label
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@ast
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@en
prefLabel
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@ast
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@en
P2093
P1433
P1476
Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
@en
P2093
Donghak Kim
Elizabeth M J Gillam
F Peter Guengerich
Tsutomu Shimada
Young-Jin Chun
P304
P356
10.1016/S0027-5107(02)00333-0
P407
P478
P577
2003-02-01T00:00:00Z